O'Keefe T L, Williams G T, Davies S L, Neuberger M S
Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK.
Science. 1996 Nov 1;274(5288):798-801. doi: 10.1126/science.274.5288.798.
CD22 is a surface glycoprotein of B lymphocytes that is rapidly phosphorylated on cytoplasmic tyrosines after antigen receptor cross-linking. Splenic B cells from mice with a disrupted CD22 gene were found to be hyperresponsive to receptor signaling: Heightened calcium fluxes and cell proliferation were obtained at lower ligand concentrations. The mice gave an augmented immune response, had an expanded peritoneal B-1 cell population, and contained increased serum titers of autoantibody. Thus, CD22 is a negative regulator of antigen receptor signaling whose onset of expression at the mature B cell stage may serve to raise the antigen concentration threshold required for B cell triggering.
CD22是B淋巴细胞的一种表面糖蛋白,在抗原受体交联后,其胞质酪氨酸会迅速发生磷酸化。研究发现,来自CD22基因敲除小鼠的脾B细胞对受体信号反应过度:在较低配体浓度下即可出现增强的钙流和细胞增殖。这些小鼠表现出增强的免疫反应,腹膜B-1细胞群体扩大,血清自身抗体滴度升高。因此,CD22是抗原受体信号的负调节因子,其在成熟B细胞阶段开始表达可能有助于提高B细胞触发所需的抗原浓度阈值。